Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 3, Pages e89974
Publisher
Public Library of Science (PLoS)
Online
2014-03-21
DOI
10.1371/journal.pone.0089974
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
- (2013) Lauri E. Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
- (2013) Amy Leval et al. JNCI-Journal of the National Cancer Institute
- Australia launches national scheme to vaccinate boys against HPV
- (2013) D. Brill BMJ-British Medical Journal
- Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
- (2013) H. Ali et al. BMJ-British Medical Journal
- Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
- (2012) E A Burger et al. BRITISH JOURNAL OF CANCER
- The Cost Effectiveness of Human Papillomavirus Vaccines
- (2012) Katherine Seto et al. DRUGS
- Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
- (2012) Wiebren A. Tjalma et al. INTERNATIONAL JOURNAL OF CANCER
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Epidemiological aspects of recurrent respiratory papillomatosis: A population-based study
- (2012) Turid Omland et al. LARYNGOSCOPE
- Quality of life valuations of HPV-associated cancer health states by the general population
- (2012) E Lynne Conway et al. SEXUALLY TRANSMITTED INFECTIONS
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity
- (2011) Marc Brisson et al. JOURNAL OF INFECTIOUS DISEASES
- The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK
- (2011) S. C. Woodhall et al. SEXUALLY TRANSMITTED INFECTIONS
- The cost-effectiveness of male HPV vaccination in the United States
- (2011) Harrell W. Chesson et al. VACCINE
- Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases
- (2010) Jon Mork et al. CANCER CAUSES & CONTROL
- Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
- (2010) Jens Olsen et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Impact of vaccinating boys and men against HPV in the United States
- (2010) Elamin H. Elbasha et al. VACCINE
- Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria
- (2009) Ingrid Zechmeister et al. VACCINE
- Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
- (2009) Yoon Hong Choi et al. VACCINE
- Health and Economic Implications of HPV Vaccination in the United States
- (2008) Jane J. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started